1. Home
  2. IVP vs PRFX Comparison

IVP vs PRFX Comparison

Compare IVP & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVP
  • PRFX
  • Stock Information
  • Founded
  • IVP 2020
  • PRFX 2007
  • Country
  • IVP United States
  • PRFX Israel
  • Employees
  • IVP N/A
  • PRFX 6
  • Industry
  • IVP Diversified Commercial Services
  • PRFX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IVP Miscellaneous
  • PRFX Health Care
  • Exchange
  • IVP Nasdaq
  • PRFX Nasdaq
  • Market Cap
  • IVP 3.3M
  • PRFX 3.3M
  • IPO Year
  • IVP 2023
  • PRFX 2020
  • Fundamental
  • Price
  • IVP $0.94
  • PRFX $1.69
  • Analyst Decision
  • IVP
  • PRFX Hold
  • Analyst Count
  • IVP 0
  • PRFX 1
  • Target Price
  • IVP N/A
  • PRFX N/A
  • AVG Volume (30 Days)
  • IVP 2.9M
  • PRFX 8.5M
  • Earning Date
  • IVP 08-13-2025
  • PRFX 08-29-2025
  • Dividend Yield
  • IVP N/A
  • PRFX N/A
  • EPS Growth
  • IVP N/A
  • PRFX N/A
  • EPS
  • IVP N/A
  • PRFX N/A
  • Revenue
  • IVP $15,292,904.00
  • PRFX N/A
  • Revenue This Year
  • IVP N/A
  • PRFX N/A
  • Revenue Next Year
  • IVP N/A
  • PRFX N/A
  • P/E Ratio
  • IVP N/A
  • PRFX N/A
  • Revenue Growth
  • IVP N/A
  • PRFX N/A
  • 52 Week Low
  • IVP $0.63
  • PRFX $1.25
  • 52 Week High
  • IVP $83.93
  • PRFX $16.63
  • Technical
  • Relative Strength Index (RSI)
  • IVP 51.97
  • PRFX 54.34
  • Support Level
  • IVP $0.81
  • PRFX $1.57
  • Resistance Level
  • IVP $0.97
  • PRFX $3.59
  • Average True Range (ATR)
  • IVP 0.11
  • PRFX 0.22
  • MACD
  • IVP 0.03
  • PRFX 0.05
  • Stochastic Oscillator
  • IVP 40.43
  • PRFX 18.80

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: